Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers.

A cDNA clone encoding human SRBC [serum deprivation response factor (sdr)-related gene product that binds to c-kinase] was isolated in a yeast two-hybrid screening, with amino acids 1-304 of BRCA1 as the probe. The human SRBC gene (hSRBC) was mapped to chromosome region 11p15.5-p15.4, close to marker D11S1323, at which frequent loss of heterozygosity (LOH) has been observed in sporadic breast, lung, ovarian, and other types of adult cancers as well as childhood tumors. hSRBC-coding region mutations including frame shift and truncation mutations were detected in a few ovarian and lung cancer cell lines. More significantly, the expression of hSRBC protein was down-regulated in a large fraction [30 (70%) of 43] of breast, lung, and ovarian cancer cell lines, whereas strong expression of hSRBC protein was detected in normal mammary and lung epithelial cells. The down-regulation of hSRBC expression in cancer cells was associated with hypermethylation of CpG dinucleotides in its promoter region, and 3 (60%) of 5 primary breast tumors and 11 (79%) of 14 primary lung tumors were also found to be hypermethylated. Treatment of breast cancer MCF7 cells with 5'azacytidine and Trichostatin A resulted in expression of hSRBC, confirming DNA methylation as the mode of inactivation. Our results suggest that epigenetic or mutational inactivation of hSRBC may contribute to the pathogenesis of several types of human cancers, marking hSRBC as a candidate tumor suppressor gene.

[1]  J. Minna,et al.  PANORAMA: an integrated Web-based sequence analysis tool and its role in gene discovery. , 2000, Genomics.

[2]  J. Minna,et al.  Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. , 2000, Cancer research.

[3]  B. Koller,et al.  Brca1 controls homology-directed DNA repair. , 1999, Molecular cell.

[4]  S. Gustincich,et al.  The human serum deprivation response gene (SDPR) maps to 2q32-q33 and codes for a phosphatidylserine-binding protein. , 1999, Genomics.

[5]  J. Minna,et al.  Enrichment of epithelial cells for molecular studies , 1999, Nature Medicine.

[6]  M. Gschwendt,et al.  Protein kinase C delta. , 1999 .

[7]  Peter A. Jones,et al.  Cancer-epigenetics comes of age , 1999, Nature Genetics.

[8]  B. Koller,et al.  BRCA1 required for transcription-coupled repair of oxidative DNA damage. , 1998, Science.

[9]  B. Williams,et al.  Loss of heterozygosity at chromosome 11p15 in Wilms tumors: identification of two independent regions , 1998, Oncogene.

[10]  U. Hoffmann‐Rohrer,et al.  Cloning and functional characterization of PTRF, a novel protein which induces dissociation of paused ternary transcription complexes , 1998, The EMBO journal.

[11]  Richard G. W. Anderson,et al.  Targeting of Protein Kinase Cα to Caveolae , 1998, The Journal of cell biology.

[12]  B. Williams,et al.  Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis. , 1998, Human molecular genetics.

[13]  J. Herman,et al.  Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.

[14]  泉裕士.  A Protein Kinase Cδ-binding Protein SRBC Whose Expression Is Induced by Serum Starvation(血清飢餓により発現が誘導される,新規プロテインキナーゼCδ結合蛋白質SRBCの同定) , 1998 .

[15]  G. Bepler,et al.  Association of chromosome 11 locus D11S12 with histology, stage, and metastases in lung cancer. , 1998, Cancer detection and prevention.

[16]  A. Bowcock,et al.  Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Bepler,et al.  Growth inhibition of a human lung adenocarcinoma cell line by genetic complementation with chromosome 11. , 1997, Anticancer research.

[18]  F. Baas,et al.  Allelotype of pediatric rhabdomyosarcoma , 1997, Oncogene.

[19]  N. Nowak,et al.  A 1-Mb physical map and PAC contig of the imprinted domain in 11p15.5 that contains TAPA1 and the BWSCR1/WT2 region. , 1997, Genomics.

[20]  W. Reik,et al.  Imprinting in clusters: lessons from Beckwith-Wiedemann syndrome. , 1997, Trends in genetics : TIG.

[21]  G. Bepler,et al.  Delineation of the centromeric and telomeric chromosome segment 11p15.5 lung cancer suppressor regions LOH11A and LOH11B , 1997, Genes, chromosomes & cancer.

[22]  Anne M. Bowcock,et al.  Identification of a RING protein that can interact in vivo with the BRCA1 gene product , 1996, Nature Genetics.

[23]  T. Kensler,et al.  Isolation of cDNAs representing dithiolethione-responsive genes. , 1996, Carcinogenesis.

[24]  I. Newsham,et al.  High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas. , 1996, Cancer research.

[25]  S. Hirohashi,et al.  Deletion mapping of chromosome 2 in human lung carcinoma , 1996, Genes, chromosomes & cancer.

[26]  D. Gerhard,et al.  Localization of a tumor suppressor gene in 11p15.5 using the G401 Wilms' tumor assay. , 1996, Human molecular genetics.

[27]  M. Rugge,et al.  Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. , 1996, Cancer research.

[28]  J. Yokota,et al.  Breakpoint junction of interstitial homozygous deletion at chromosome 2q33 in a small cell lung carcinoma. , 1996, DNA research : an international journal for rapid publication of reports on genes and genomes.

[29]  J. Gudmundsson,et al.  Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. , 1995, British Journal of Cancer.

[30]  G. Hampton,et al.  Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. , 1995, Cancer research.

[31]  G. Hampton,et al.  Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. , 1995, Cancer research.

[32]  M. Knowles,et al.  Deletion mapping of chromosome II in carcinoma of the bladder , 1995 .

[33]  J. Minna,et al.  Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. , 1995, JAMA.

[34]  M. Skolnick,et al.  BRCA1 mutations in primary breast and ovarian carcinomas. , 1994, Science.

[35]  A. von Deimling,et al.  Loss of maternal alleles on chromosome arm 11p in hepatoblastoma. , 1994, Cancer research.

[36]  S. Seal,et al.  Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.

[37]  S. Clark,et al.  High sensitivity mapping of methylated cytosines. , 1994, Nucleic acids research.

[38]  P. Zimmerman,et al.  Correlation of loss of heterozygosity at 11 p with tumour progression and survival in non‐small cell lung cancer , 1994, Genes, chromosomes & cancer.

[39]  L. Simms,et al.  Three non‐overlapping regions of chromosome arm 11p allele loss identified in infantile tumors of adrenal and liver , 1993, Genes, chromosomes & cancer.

[40]  S. Gustincich,et al.  Serum deprivation response gene is induced by serum starvation but not by contact inhibition. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[41]  D. Easton,et al.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. , 1993, American journal of human genetics.

[42]  W. Lissens,et al.  Deletion of chromosome 11p13-11p15.5 sequences in invasive human ovarian cancer is a subclonal progression factor. , 1992, Cancer research.

[43]  A. Viel,et al.  Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours. , 1992, British Journal of Cancer.

[44]  B. Weissman,et al.  Suppression of tumorigenicity in Wilms tumor by the p15.5-p14 region of chromosome 11. , 1991, Science.

[45]  T. Ganz,et al.  Purification and characterization of a major phosphatidylserine-binding phosphoprotein from human platelets. , 1990, The Biochemical journal.

[46]  W. Cavenee,et al.  Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. , 1989, American journal of human genetics.

[47]  A. Reeve,et al.  Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells , 1989, Molecular and cellular biology.

[48]  Iqbal Unnisa Ali,et al.  Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia , 1987 .

[49]  T. Sugimura,et al.  Activation of human c-raf-1 by replacing the N-terminal region with different sequences. , 1987, Nucleic acids research.

[50]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .